{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:27:42Z","timestamp":1759624062021,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.ejogrb.2005.08.015","type":"journal-article","created":{"date-parts":[[2005,9,20]],"date-time":"2005-09-20T09:03:42Z","timestamp":1127207022000},"page":"155-159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Evaluation of the maternal and umbilical vein serum sFas\/sFasL system in pregnancies complicated by preeclampsia with intrauterine growth retardation"],"prefix":"10.1016","volume":"126","author":[{"given":"Marzena","family":"Laskowska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Laskowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo\u017cena","family":"Leszczy\u0144ska-Gorzelak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Oleszczuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2005.08.015_bib1","first-page":"271","article-title":"Placental apoptosis in preeclampsia","volume":"96","author":"Allaire","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2005.08.015_bib2","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.placenta.2004.02.004","article-title":"Fetal growth restriction: a workshop report","volume":"25","author":"Cetin","year":"2004","journal-title":"Placenta"},{"key":"10.1016\/j.ejogrb.2005.08.015_bib3","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0002-9440(10)63857-6","article-title":"Differences in apoptotic susceptibility of cytotrophoblasts and syncytiotrophoblasts in normal pregnancy to those complicated with preeclampsia and intrauterine growth restriction","volume":"162","author":"Crocker","year":"2003","journal-title":"Am J Pathol"},{"issue":"8","key":"10.1016\/j.ejogrb.2005.08.015_bib4","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/labinvest.3780326","article-title":"Macrophage-induced apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women","volume":"81","author":"Reister","year":"2001","journal-title":"Lab Invest"},{"issue":"6","key":"10.1016\/j.ejogrb.2005.08.015_bib5","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/S0002-9378(97)70081-4","article-title":"Increased placental apoptosis in intrauterine growth restriction","volume":"177","author":"Smith","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2005.08.015_bib6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0002-9378(97)70438-1","article-title":"Placental apoptosis in normal human pregnancy","volume":"177","author":"Smith","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2005.08.015_bib7","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/jama.279.4.300","article-title":"To die or not to die. An overview of apoptosis and its role in disease","volume":"279","author":"Hetts","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.ejogrb.2005.08.015_bib8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.med.48.1.267","article-title":"Apoptosis and disease: regulation and clinical relevance of programmed cell death","volume":"48","author":"Rudin","year":"1997","journal-title":"Ann Rev Med"},{"key":"10.1016\/j.ejogrb.2005.08.015_bib9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jri.2003.10.001","article-title":"Preeclampsia: associated with increased syncytial apoptosis when the infant is small-for-gestational-age","volume":"61","author":"Austgulen","year":"2004","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.ejogrb.2005.08.015_bib10","first-page":"195","article-title":"Immunohistochemical evaluation of apoptosis in placentae from normal and intrauterine growth-restricted pregnancies","volume":"26","author":"Axt","year":"1999","journal-title":"Clin Exp Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2005.08.015_bib11","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1053\/plac.2000.0538","article-title":"Telomerase activity and apoptosis as indicator of aging in placenta with and without intrauterine growth retardation","volume":"21","author":"Kudo","year":"2000","journal-title":"Placenta"},{"key":"10.1016\/j.ejogrb.2005.08.015_bib12","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0891-5849(96)00171-2","article-title":"Fetal growth retardation in rats may results from apoptosis: role of peroxynitrite","volume":"21","author":"Miller","year":"1996","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.ejogrb.2005.08.015_bib13","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0952-7915(98)80222-7","article-title":"Mechanisms of CD95 (APO-1\/Fas)-mediated apoptosis","volume":"10","author":"Peter","year":"1998","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.ejogrb.2005.08.015_bib14","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1126\/science.7510905","article-title":"Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule","volume":"263","author":"Cheng","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.ejogrb.2005.08.015_bib15","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nm0396-317","article-title":"Fas ligand in human serum","volume":"2","author":"Tanaka","year":"1996","journal-title":"Nat Med"},{"issue":"5394","key":"10.1016\/j.ejogrb.2005.08.015_bib16","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1126\/science.282.5394.1714","article-title":"Regulation of the proinflammatory effects of Fas ligand","volume":"282","author":"Chen","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.ejogrb.2005.08.015_bib17","series-title":"Proceedings of the 19th Annual Meeting of the Society for Maternal-Fetal Medicine","article-title":"Elevated serum soluble Fas\/APO-1 in preeclampsia","author":"Hsu","year":"1999"},{"key":"10.1016\/j.ejogrb.2005.08.015_bib18","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000052901","article-title":"Plasma levels of soluble Fas during normal pregnancy","volume":"5192","author":"Hoshimoto","year":"2001","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.ejogrb.2005.08.015_bib19","first-page":"530","article-title":"Serum soluble Fas levels in preeclampsia","volume":"97","author":"Hsu","year":"2001","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ejogrb.2005.08.015_bib20","first-page":"295","article-title":"Serum soluble Fas in the syndrome hemolysis, elevated liver enzymes, and low platelets","volume":"98","author":"Harirah","year":"2001","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ejogrb.2005.08.015_bib21","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1086\/515700","article-title":"Membrane and soluble forms of Fas (CD95) and Fas ligand in peripheral blood mononuclear cells and in plasma from human immunodeficiency virus-infected persons","volume":"178","author":"Hosaka","year":"1998","journal-title":"J Infect Dis"},{"issue":"9120","key":"10.1016\/j.ejogrb.2005.08.015_bib22","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/S0140-6736(05)78614-1","article-title":"Raised plasma soluble Fas and Fas ligand in alcoholic liver disease","volume":"351","author":"Taieb","year":"1998","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ejogrb.2005.08.015_bib23","first-page":"150","article-title":"New kids in the block: the role of FasL and Fas in kidney damage","volume":"12","author":"Ortiz","year":"1999","journal-title":"J Nephrol"},{"issue":"7","key":"10.1016\/j.ejogrb.2005.08.015_bib24","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/00007890-199904150-00027","article-title":"Apoptosis and the expression of Fas and Fas ligand (FasL) antigen in rejection and reinfection in liver allograft specimens","volume":"67","author":"Tannapfel","year":"1999","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.ejogrb.2005.08.015_bib25","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1053\/j.gastro.2003.11.054","article-title":"Placenta-derived CD95 ligand causes liver damage in hemolysis, elevated liver enzymes, and low platelet count syndrome","volume":"126","author":"Strand","year":"2004","journal-title":"Gastroenterology"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211505004227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211505004227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:15:19Z","timestamp":1759554919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211505004227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0301211505004227"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2005.08.015","relation":{},"ISSN":["0301-2115"],"issn-type":[{"type":"print","value":"0301-2115"}],"subject":[],"published":{"date-parts":[[2006,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the maternal and umbilical vein serum sFas\/sFasL system in pregnancies complicated by preeclampsia with intrauterine growth retardation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2005.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}